Plain-English translation of NCT07205120 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a device called the Cardiac Scale paired with a software tool to help manage heart failure by monitoring your body's fluid levels at home. Instead of waiting for symptoms to get worse, doctors will use alerts from the device to adjust your care early. The goal is to see if this approach helps prevent future hospital visits and improves your overall health.
Heart failure patients often end up back in the hospital because fluid builds up in their body and doctors don't catch it in time. This study hopes that by catching fluid problems early through daily home monitoring, doctors can make small treatment adjustments before things get serious.
You likely qualify if…
You likely don't qualify if…
You will use the Cardiac Scale device at home in your regular outpatient setting while continuing your normal heart failure care with your doctors. You'll have follow-up study visits at 45 days and 90 days where researchers will check on your health, review any hospital visits or changes to your medications, and make sure the device is helping. Throughout the study, your doctors will use alerts from the device to guide decisions about adjusting your fluid management and medications.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
United States
Sponsor
Bodyport Inc.
Enrollment target
~50 participants
Started
October 2025
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
21 Years and older
Last updated on clinicaltrials.gov in November 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.